We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Desperate Muscle Cells Produce Nerve Regenerating MicroRNA

By LabMedica International staff writers
Posted on 21 Dec 2009
Neuroscientists are investigating the possible therapeutic applications of a class of microRNA (miRNA) produced by damaged muscle cells in patients with amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease).

ALS is a neurodegenerative disease with no known cause characterized by loss of motor neurons, denervation of target muscles, muscle atrophy, and paralysis. More...
As the disease progresses and muscle tissues begin to degenerate due to lack of nerve stimulation, muscle cells produce various molecules aimed at stimulating regeneration of nerves.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) studied one of these molecules, the microRNA miR-206. They reported in the December 11, 2009 issue of the journal Science that the skeletal muscle specific miRNA-206 was a key regulator of nerve regeneration signaling, and that it was dramatically induced in a mouse model of ALS. Mice that were genetically deficient in miR-206 formed normal neuromuscular synapses during development, but deficiency of miR-206 in the ALS mouse model accelerated disease progression. MiR-206 was required for efficient regeneration of neuromuscular synapses after acute nerve injury, which, thought the investigators, probably accounted for its salutary effects in ALS.

"MiR-206 seems to sense nerve injury and promote regeneration," said senior author Dr. Eric Olson, professor of molecular biology at the University of Texas Southwestern Medical Center. "While miR-206 initially prompts nearby surviving nerves to send new branches to the muscles, it only delays the inevitable. Our findings correlate with the observation in ALS patients that the disease is nearly asymptomatic until a large fraction of motor neurons has died, at which point the few remaining ones cannot compensate sufficiently. These results provide a new perspective on the mechanisms of ALS. Because miR-206 only exists in skeletal muscle, a drug based on it might not affect other tissues. That limits its risk of side effects and is a key part of its appeal as a potential therapy."

Related Links:
University of Texas Southwestern Medical Center



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
POC Immunoassay Analyzer
Procise DX
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.